Meet Delphinus Venture Capital, new Aarhus-based €80M venture fund launched to…
The Aarhus University Research Foundation join hands with these local firms to drive growth in the startup ecosystem across these regions.
Popular topics
Where the capital lands, who writes the cheque, and what gets built with it. Funding rounds, venture capital flows, and the deal-making that shapes which technology companies scale.
6,932 articles · Funding
The Aarhus University Research Foundation join hands with these local firms to drive growth in the startup ecosystem across these regions.
Plancraft has secured funding to drive its AI-powered transformation of the construction industry across Europe.
Oculis has amended its loan facility with BlackRock, increasing potential access to CHF 100M. The company develops therapies for ophthalmic and neuro-ophthalmic diseases.
London-based TILKI outlined its plans for platform development, community features, and broader market participation, supported by investment from several venture firms.
Riva Money has secured funding to develop its payment platform and expand its market presence.
EDGX has raised €2.3M to develop AI edge computing technology for satellites.
Three 22-year-olds in Germany have secured pre-seed investment for their company developing an AI-powered tool designed to assist teachers throughout the teaching cycle.
Switzerland and US-based Energy Vault, a company specialised in grid-scale energy storage solutions, announced it has entered into an exclusivity agreement for a $300M (approximately €258M) preferred equity investment.
Riga-based Cellbox Labs, a company developing organs on a chip that are miniature organ replicas outside the human body, has secured €3.3M in non-dilutive funding to accelerate the development of its technology.
The Hague-based Bubty, a global Freelance Management System (FMS), has been acquired by Upwork’s new enterprise subsidiary.
Copenhagen-based SNIPR Biome, a biotech company focused on developing precision medicines through CRISPR technology for microbial gene therapy, has successfully secured €35M in a Series B funding round.